Literature DB >> 350348

Cell-mediated immunity during syphilis.

C S Pavis, J D Folds, J B Baseman.   

Abstract

Evidence is presented which reinforces the complexity of the host-parasite interaction during the course of syphilis. Infection with Treponema pallidum evokes a complicated antibody response and an assortment of cell-mediated immune reactions in the host. It appears that humoral immunity plays a minor role towards the complete elimination of syphilitic infection while the cellular limb of the immune response may be an important host defence mechanism. Information now available indicates that a state of anergy, or immunosuppression, exists in the early stages of human and experimental rabbit syphilis based upon negative skin reactions to T. pallidum antigen(s), the abnormal histological appearance of lymphoid organs, and impaired in vitro lymphocyte reactivity. It is also evident that in the later stages of the disease cellular immunity becomes activated as delayed type skin reactions can normally be elicited in tertiary syphilitics and lymphocyte behaviour in cell culture appears normal. Several mechanisms have been invoked to explain the delay in an effective immune response against syphilitic infection and the duration of the disease: (1) a capsule-like substance on the outer surface of virulant T. pallidum may act as a barrier against treponemicidal antibody; (2) this material and other biological properties of virulent treponemes could enable spirochaetes to escape being engulfed by macrophages and other phagocytic cells; (3) antigenic competition among different treponemal antigens causing partial tolerance; (4) T. pallidum infection may bring about the elaboration of immunosuppressive substances of host or treponemal origin which inhibit the proper function of lymphocytes, macrophages, and other cell types.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350348      PMCID: PMC1045478          DOI: 10.1136/sti.54.3.144

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


  43 in total

1.  Protective layer covering pathogenic treponemata.

Authors:  S CHRISTIANSEN
Journal:  Lancet       Date:  1963-02-23       Impact factor: 79.321

2.  A study of the role of serum and tissue lysozyme upon the treponeme immobilization reaction.

Authors:  M METZGER
Journal:  Am J Hyg       Date:  1962-11

3.  Influence of lysozyme upon the treponeme immobilization reaction.

Authors:  M METZGER; P H HARDY; E E NELL
Journal:  Am J Hyg       Date:  1961-03

4.  [Study on intradermal reaction to formol Treponema suspensions in syphilitics and normal subjects].

Authors:  J THIVOLET; A SIMERAY; M ROLLAND; F CHALLUT
Journal:  Ann Inst Pasteur (Paris)       Date:  1953-07

5.  Relationship between treponemal immobilizing antibodies and acquired immunity in experimental syphilis.

Authors:  H J MAGNUSON; F A THOMPSON; C P McLEOD
Journal:  J Immunol       Date:  1951-07       Impact factor: 5.422

6.  Selective in vitro response of thymus-derived lymphocytes from Treponema pallidum-infected rabbits.

Authors:  C S Pavia; J D Folds; J B Baseman
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

7.  Cell-mediated immunity in experimental syphilis in rabbits.

Authors:  M Metzger; J Podwińska; W Smogór
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  1977       Impact factor: 4.291

8.  Selective response of lymphocytes from Treponema pallidum-infected rabbits to mitogens and Treponema reiteri.

Authors:  C S Pavia; J B Baseman; J D Folds
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

9.  Reactivity of lymphocytes from patients with syphilis towards T. pallidum antigen in the leucocyte migration and lymphocyte transformation tests.

Authors:  E From; K Thestrup-Pedersen; H Thulin
Journal:  Br J Vener Dis       Date:  1976-08

10.  Development of of macrophage migration inhibition in rabbits infected with virulent Treponema pallidum.

Authors:  C S Pavia; J D Folds; J B Baseman
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

View more
  40 in total

1.  Immune studies in infants with congenital syphilis.

Authors:  G R Samson; D W Beatty; A F Malan
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

2.  Risk factors for A.I.D.S. among homosexual men in France.

Authors:  A Messiah; J Y Mary; J B Brunet; W Rozenbaum; M Gentilini; A J Valleron
Journal:  Eur J Epidemiol       Date:  1988-03       Impact factor: 8.082

3.  Possible suppressor T lymphocyte activity in experimental syphilis.

Authors:  D J Wright; D J Frost
Journal:  Br J Vener Dis       Date:  1979-02

4.  Infiltrate of syphilitic lesions before and after treatment.

Authors:  A Tosca; J Lehou; M Hatjivasiliou; A Varelzidis; J D Stratigos
Journal:  Genitourin Med       Date:  1988-10

5.  Murine monoclonal antibodies specific for virulent Treponema pallidum (Nichols).

Authors:  S M Robertson; J R Kettman; J N Miller; M V Norgard
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

6.  Sequential changes in susceptibility to Treponema pallidum of rabbits previously infected with Treponema paraluis-cuniculi.

Authors:  S Graves
Journal:  Br J Vener Dis       Date:  1981-02

7.  Experimental infection of man with rabbit-virulent Treponema paraluis-cuniculi.

Authors:  S Graves; J Downes
Journal:  Br J Vener Dis       Date:  1981-02

8.  Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness.

Authors:  J E Craft; D K Fischer; G T Shimamoto; A C Steere
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

9.  Treponemal infection specifically enhances node T-cell regulation of macrophage activity.

Authors:  D R Tabor; O Bagasra; R F Jacobs
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

10.  Enhanced primary resistance to Treponema pallidum infection and increased susceptibility to toxoplasmosis in T-cell-depleted guinea pigs.

Authors:  C S Pavia
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.